In vivo modulation of several anticancer agents by beta-carotene
- PMID: 8004757
- DOI: 10.1007/BF00685083
In vivo modulation of several anticancer agents by beta-carotene
Abstract
The ability of the collagenase inhibitor minocycline and of beta-carotene to act as positive modulators of cytotoxic anticancer agents was assessed in vitro and in vivo. Cell-culture studies were conducted using the human SCC-25 squamous carcinoma cell line. Simultaneous exposure of the cells to minocycline and beta-carotene or 13-cis-retinoic acid along with cisplatin (CDDP) resulted in a small decrease in the cytotoxicity of the CDDP. The addition of each of the modulator combinations for 1 h or 24 h to treatment with melphalan (L-PAM) or carmustine (BCNU) resulted in greater-than-additive cytotoxicity with each of four regimens. The modulator combinations of minocycline and beta-carotene applied for 1 h or 24 h and the modulator combination of minocycline and 13-cis-retinoic acid produced greater-than-additive cytotoxicity at 50 microM 4-hydroperoxycyclophosphamide (4-HC), whereas minocycline and 13-cis-retinoic acid applied for 1 h was antagonistic with 4-HC and the other modulator treatments at low concentrations of 4-HC resulted in subadditive cytotoxicity. The effect of treatment with beta-carotene alone and in combination with several different anticancer agents was examined in two murine solid tumors, the FSaII fibrosarcoma and the SCC VII carcinoma. Administration of the modulators alone or in combination did not alter the growth of either tumor. Whereas increases in tumor growth delay occurred with the antitumor alkylating agents and beta-carotene and with minocycline and beta-carotene, a diminution in tumor growth delay was produced by 5-fluorouracil in the presence of these modulators. The modulator combination also resulted in increased tumor growth delay with adriamycin and etoposide. Tumor-cell survival assay showed increased killing of FSaII tumor cells with the modulator combination and melphalan or cyclophosphamide as compared with the drugs alone. These results indicate that further investigation of this modulator strategy is warranted.
Similar articles
-
beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.Cancer Chemother Pharmacol. 1993;33(3):229-38. doi: 10.1007/BF00686221. Cancer Chemother Pharmacol. 1993. PMID: 8269604
-
Beta-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells.Cancer Chemother Pharmacol. 1992;29(3):207-13. doi: 10.1007/BF00686254. Cancer Chemother Pharmacol. 1992. PMID: 1733553
-
Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.Cancer Chemother Pharmacol. 1992;30(5):377-84. doi: 10.1007/BF00689966. Cancer Chemother Pharmacol. 1992. PMID: 1505076
-
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.Cancer Res. 1991 Feb 15;51(4):1086-91. Cancer Res. 1991. PMID: 1825474
-
13-cis-retinoic acid, beta-carotene and other anti-oxidant agents in chemoprevention and therapy of head and neck cancer.Eur J Cancer Prev. 1994 Jul;3(4):374-7. doi: 10.1097/00008469-199407000-00016. Eur J Cancer Prev. 1994. PMID: 7950898 Review. No abstract available.
Cited by
-
Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes.Lipids. 1995 Nov;30(11):1029-34. doi: 10.1007/BF02536288. Lipids. 1995. PMID: 8569431
-
Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells.Exp Ther Med. 2015 Feb;9(2):585-590. doi: 10.3892/etm.2014.2101. Epub 2014 Dec 3. Exp Ther Med. 2015. PMID: 25574239 Free PMC article.
-
Antioxidant Antagonises Chemotherapeutic Drug Effect in Lung Cancer Cell Line A549.Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1019-1023. doi: 10.31557/APJCP.2020.21.4.1019. Asian Pac J Cancer Prev. 2020. PMID: 32334464 Free PMC article.
-
A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).Cancer Metastasis Rev. 1996 Jun;15(2):247-72. doi: 10.1007/BF00437479. Cancer Metastasis Rev. 1996. PMID: 8842498 Review. No abstract available.
-
In silico screening for potential inhibitors from the phytocompounds of Carica papaya against Zika virus NS5 protein.F1000Res. 2024 Jun 25;12:655. doi: 10.12688/f1000research.134956.2. eCollection 2023. F1000Res. 2024. PMID: 39132582 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous